We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Moderna Therapeutics, carrying a valuation in the billions of dollars and testing several mRNA vaccine programs in early stages, has a new leader in vaccines.